ROSKILDE, Denmark--(BUSINESS WIRE)--Sonion today announced the appointment of Jesper Ahlmann Funding Andersen as the President & CEO of the Sonion Group. Jesper replaces Jørn Mørkeberg Nielsen who was President & CEO of Sonion until the end of 2016.
“We look very much forward to welcoming Jesper. He brings a wealth of experience and leadership to Sonion. We expect Jesper to further develop Sonion’s strong position in the current market and develop new products to serve the potential of adjacent markets.” says Walther Thygesen, Chairman of the Sonion Board.
Jesper Ahlmann Funding Andersen, (50 yrs old, married and has 4 children), brings with him over 20 years of experience from the medico industry. Since 2014, he has been SVP of Global Sales and Marketing at Widex A/S. From 2005 to 2014, Jesper was CEO of Origio A/S, a global leader in delivering innovative Assisted Reproductive Technology solutions, and he was SVP of International Business at GN ReSound from 2001 to 2005. Jesper is M.Sc. in Business Administration from Copenhagen Business School and worked from 1990-1994 at McKinsey & Co. as a management consultant.
“I am most excited to join Sonion at this point of its development. To me Sonion is a fully globalized, very well run company, operating in an attractive niche within high tech medical components. I look most forward to – together with the strong Sonion management team – defining how best to continue and accelerate Sonions growth journey and as part of that defining which segments to explore further”.
Sonion is a global leader in micro acoustic and micro mechanical technologies and solutions for hearing instruments, in-ear earphones and specialty headsets. The Sonion Group is owned by Novo A/S which is the holding company within the Novo Group that manages the assets of the Novo Nordisk Foundation.